Community-led intervention curbs childhood obesity and boosts quality of life

The RESPOND trial adapted to COVID-19 disruptions by shifting to a cluster-parallel randomized design, enabling analysis despite the pandemic’s impact on school and community participation rates.

Damages from tornado at Pfizer plant could compound challenges of drug shortages

The tornado that struck parts of North Carolina on Wednesday not only damaged the immediate area, but could soon make it much harder for countless

July 20, 2023

Sciensus names Christian Tucat as Chief Executive Officer

With the appointment of Christian Tucat as CEO, Sciensus aims to leverage insights and expand its global reach in delivering lifesaving drugs and therapies.

October 18, 2024

Atara’s T cell programmes hit with clinical hold after third-party site woes – Pharmaceutical Technology

Atara said it has discussed and agreed with the FDA “upon the actions necessary to release the clinical holds”. Image credit: Shutterstock / Lamar Belina.

January 22, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.